Kafrelsheikh University: COVID-19 trials

The registry lists 12 COVID-19 studies with Kafrelsheikh University as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 4Phase 3 1Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Could Docosahexaenoic Acid (DHA), Contained in Breast Milk and Artificial Baby Milks, Protect Infants and Children From COVID-19 and Make Them Less Prone to COVID-19-related Severe Illness Than Adults?Status unknownNCT05075031
• Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.Status unknownNCT05002530Phase 4
• Prevalence of Oral Lesions in COVID-19 PatientsCompletedNCT04917549
• Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.Status unknownNCT04730895Phase 1/2
• Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?Status unknownNCT04623385Phase 4
• Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)Status unknownNCT04578236Phase 2
• Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19Status unknownNCT04577378Phase 2
• Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19Status unknownNCT04568096Phase 2
• Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory ComplicationsStatus unknownNCT04382950Phase 1
• Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2Status unknownNCT04375046Phase 1
• Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected PatientsStatus unknownNCT04371822Phase 1
• Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)Status unknownNCT04353180Phase 3